Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
67.74
+1.97 (3.00%)
At close: May 12, 2025, 4:00 PM
67.59
-0.15 (-0.22%)
After-hours: May 12, 2025, 7:59 PM EDT
Novo Nordisk Employees
As of December 31, 2024, Novo Nordisk had 77,349 total employees, including 76,302 full-time and 1,047 part-time employees. The number of employees increased by 13,030 or 20.26% compared to the previous year.
Employees
77,349
Change (1Y)
13,030
Growth (1Y)
20.26%
Revenue / Employee
$567,845
Profits / Employee
$195,965
Market Cap
292.03B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 77,349 | 13,030 | 20.26% |
Dec 31, 2023 | 64,319 | 9,134 | 16.55% |
Dec 31, 2022 | 55,185 | 6,707 | 13.84% |
Dec 31, 2021 | 48,478 | 3,155 | 6.96% |
Dec 31, 2020 | 45,323 | 2,065 | 4.77% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
NVO News
- 2 hours ago - 50 Fortune World's Most Admired Companies (FWMAC): 24 "Safer", 1 Ideal Buy - Seeking Alpha
- 4 hours ago - Trump calls out weight-loss drugs as target of price-cut push - Reuters
- 4 hours ago - Trump wants to slash U.S. drug prices with 'most favored nation' policy – here's what to know - CNBC
- 8 hours ago - Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet - Seeking Alpha
- 12 hours ago - Novo Nordisk Stock Is Slumping Today. Here's Why. - Barrons
- 14 hours ago - Novo Nordisk: Nothing Has Changed, Except That It's Cheaper Now - Seeking Alpha
- 15 hours ago - Global Pharma Stocks Fall as Trump Plans to Cut Drug Prices - WSJ
- 17 hours ago - Pharmaceutical stocks slide as Trump vows to cut US prescription drug prices ‘by 30-80%' - The Guardian